tailieunhanh - Chronic Viral Hepatitis - part 6

mãn tính viêm gan C: tác động của tăng liều lượng và thời gian điều trị về tỉ lệ đáp ứng. Kết quả của thử nghiệm đầu tiên của Úc đa. Úc Viêm gan siêu vi C Study Group. J Hepatol năm 1995; 23: 487-496. 16. Poynard T, Bedossa P, Chevallier MA, et al. So sánh ba interferon alfa2b chế độ điều trị lâu dài của A viêm gan mãn tính | Chapter 8 CHC Treatment 163 15. Lin R Roach E Zimmerman M et al. Interferon alfa-2b for chronic hepatitis C effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group. J Hepatol 1995 23 487-496. 16. Poynard T Bedossa P Chevallier MA et al. Comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A non-B hepatitis. N Engl J Med 1995 322 1457-1462. 17. Saracco G Rosina F Abate ML et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon a-2b. Hepatology 1993 18 1300-1305. 18. Shiffman ML Hofmann CM Thompson EB et al. Relationship between biochemical virological and histological response during interferon treatment of chronic hepatitis C. Hepatology 1997 26 780-785. 19. Castilla A. Prieto J Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991 324 933940. 20. Marcellin P Boyer N Gervais A et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997 127 875881. 21. Reichard O Glaumann H Fryden A et al. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J Hepatol 1999 30 783-787. 22. Schvarcz R Glaumann H Weiland O et al. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A non-B hepatitis. Liver 1991 11 30-38. 23. Nelson DR Lau JYN. Pathogenesis of chronic hepatitis C virus infection. In Therapies for Viral Hepatitis Schinazi RF Sommadossi J-P Thomas HC eds. London International Medical 1998 8 65-76. 24. Davis GL Nelson DR Reyes GR. Future options in the management of hepatitis C. Semin Liver Dis 1999 19 Suppl 1 103-112. 25. Bodenheimer HC Lefkowitch J Lindsay K et al. Histological .